Clinical Trial Update: Multi-centre Study to Assess the Long-term Performance of the Deltamotion Cup System in Primary Hip Replacement Surgery [Phase 4]

View source ↗

Summary

A multi-centre Phase 4 trial evaluating the long-term performance of the Deltamotion Cup System for primary hip replacement was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Avascular Necrosis
• Congenital Hip Dysplasia
• Osteoarthritis
• Post-traumatic Arthritis
• Rheumatoid Arthritis
• Traumatic Femoral Fractures

Drugs mentioned

• Deltamotion Cup System

Snippet

Sponsor: DePuy International | Conditions: Rheumatoid Arthritis, Osteoarthritis | Phase 4 | Status: TERMINATED